NeoGenomics NEO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$17.11M-73.1% | -$9.88M+63.6% | -$27.13M+39.8% | -$45.09M-73.9% | -$25.92M-69.2% | ||
| $8.78M+0.2% | $8.76M-0.5% | $8.8M-3.7% | $9.14M-2.4% | $9.37M-4.7% | ||
| $9.64M+19.8% | $8.04M-22.0% | $10.31M-15.6% | $12.21M+13.6% | $10.75M+29.1% | ||
| -$8.14M-706% | $1.34M-84.9% | $8.88M-56.3% | $20.33M+180% | -$25.33M-358% | ||
| $5M-36.5% | $7.87M-5.3% | $8.31M+31.5% | $6.32M+40.5% | $4.5M-61.2% | ||
| -$5M+20.7% | -$6.31M-2,176% | -$277K+97.0% | -$9.31M-362% | $3.56M— | ||
| -$338K— | —— | —— | -$202.43M-21,431% | $949K+38.1% | ||
| -$13.48M-200% | -$4.5M— | $0+100% | -$191.47M-820% | -$20.82M-515% | ||
| -$13.14M-101% | -$6.53M— | —— | —— | -$29.83M-1,558% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does NeoGenomics generate?
- NeoGenomics (NEO) generated $22.4M in operating cash flow over the trailing twelve months.
- What is NeoGenomics's free cash flow?
- After $27.5M of capital expenditures, NeoGenomics's free cash flow was -$51.3M over the trailing twelve months, down 19.8% year over year.
- Where does NeoGenomics's cash flow data come from?
- Every line is extracted from NeoGenomics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
